Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases

[1]  H. Goossens,et al.  The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations , 2021, The Lancet Infectious Diseases.

[2]  Taro Yamamoto,et al.  Implications of human activities for (re)emerging infectious diseases, including COVID-19 , 2020, Journal of physiological anthropology.

[3]  Herman Goossens,et al.  The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP CAP) study: rationale and design , 2020 .

[4]  H. Goossens,et al.  Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial , 2019, The Lancet.

[5]  A. Voss,et al.  Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  R. Laxminarayan,et al.  Antibiotic development — economic, regulatory and societal challenges , 2019, Nature Reviews Microbiology.

[7]  Leonhard Held,et al.  Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Nicholl,et al.  Benefits and challenges of using the cohort multiple randomised controlled trial design for testing an intervention for depression , 2017, Trials.

[9]  J. Woodcock,et al.  Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. , 2017, The New England journal of medicine.

[10]  Jagadeeswara Rao Gaddale Clinical Data Acquisition Standards Harmonization importance and benefits in clinical data management , 2015, Perspectives in clinical research.